BioWorld Asia

Feb. 22, 2006

EU Research Funding Plan Hits New Biotech Snags

BRUSSELS, Belgium - The European Union could start pumping as much as $3 billion a year in biotechnology and health research beginning next January if its new seven-year support program wins approval. (BioWorld International) Read More

Ark’s Scavidin Increasing Anticancer Drugs’ Efficacy

Bristol Researchers Developing Cancer Therapy Based On IGF2

Bavarian Nordic Opens Austrian Front In Acambis Patent Dispute

Despite Reluctance, France Drafts Bill Covering GMOs

UK Considers Egg Donations For Use In Stem Cell Research

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 19, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 19, 2025.

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Apollo’s APL-4098 shows potent antileukemic effects

BioWorld Science

Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.